Press Releases

All Releases
View Summary Arbutus Reports Interim Multi-Dose Results from Phase II Clinical Trial of ARB-1467 in Patients with Chronic HBV Infection
Sep 29, 2016
PDF 17.2 KB Add to Briefcase
View Summary Arbutus' Chief Scientific Officer, Dr. Michael J. Sofia, Awarded the 2016 Lasker~DeBakey Clinical Medical Research Award
Sep 13, 2016
PDF 9.8 KB Add to Briefcase
View Summary Arbutus to Present at the 2016 Wedbush PacGrow Healthcare Conference
Aug 10, 2016
PDF 8.0 KB Add to Briefcase
View Summary Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology
Aug 8, 2016
PDF 12.5 KB Add to Briefcase
View Summary Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results
Aug 4, 2016
PDF 29.9 KB Add to Briefcase
View Summary Arbutus Reports Topline Results from TKM-PLK1 HCC Clinical Trial
Jul 19, 2016
PDF 15.3 KB Add to Briefcase
View Summary Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference
Jul 18, 2016
PDF 11.9 KB Add to Briefcase
View Summary Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System
Jun 30, 2016
PDF 12.2 KB Add to Briefcase
View Summary Arbutus to Participate in Upcoming Investor Conferences
Jun 3, 2016
PDF 10.6 KB Add to Briefcase
View Summary Arbutus to Present at the 5th Antiviral Drugs Research and Development Conference
Jun 1, 2016
PDF 11.3 KB Add to Briefcase
View Summary Arbutus Provides Corporate Update and Announces First Quarter 2016 Financial Results
May 4, 2016
PDF 29.0 KB Add to Briefcase
View Summary Arbutus Expands HBV Pipeline
May 3, 2016
PDF 11.3 KB Add to Briefcase
View Summary Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results
Apr 29, 2016
PDF 10.2 KB Add to Briefcase
View Summary Arbutus to Participate in Upcoming Investor Conferences
Apr 27, 2016
PDF 10.1 KB Add to Briefcase
View Summary Arbutus Presents Data from Combination Activity Studies of HBV Drug Candidates
Apr 22, 2016
PDF 15.7 KB Add to Briefcase
View Summary Arbutus Announces Planned Executive Departure
Apr 21, 2016
PDF 11.0 KB Add to Briefcase
View Summary Arbutus Presents Data on HBV Capsid Assembly Inhibitor AB-423 at EASL 2016
Apr 14, 2016
PDF 9.5 KB Add to Briefcase
View Summary Arbutus to Present Preclinical HBV Data at EASL 2016
Mar 30, 2016
PDF 11.9 KB Add to Briefcase
View Summary Arbutus Announces Year-End 2015 Financial Results
Mar 9, 2016
PDF 30.7 KB Add to Briefcase
View Summary Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel
Mar 8, 2016
PDF 9.4 KB Add to Briefcase
Showing 1-20 of 310 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase